Trend-Following Backtester · Guide · backtest 한국어

equity · US

Nurix Therapeutics, Inc. backtest

10 trend-following strategies were compared on the full daily history of Nurix Therapeutics, Inc.. 9 beat buy-and-hold CAGR; ADX / DI 방향성 ranks first by Sharpe, matching the main backtester. The return/drawdown alternative is Keltner 채널 돌파 (CAGR 7.3%, MDD -41.1%).

Data 2020-07-24 ~ 2026-07-31daily bars 1,512 (6.0 years)Costs 0.5%Venue XNASMonthly snapshot 2026-07-31

Results by strategy

9 of 10 beat buy and hold (CAGR 3.3%, drawdown -91.5%).

Sharpe leader (same as main): ADX / DI 방향성 — CAGR 21.9%, MDD -41.8%, Sharpe 0.66, 29% exposure.

Return/drawdown alternative: Keltner 채널 돌파 — CAGR is 18.6%p higher than buy and hold, while drawdown improves by 49.7%p (CAGR 7.3%, MDD -41.1%, exposure 15%).

The alternative must retain 75% of buy-and-hold CAGR, improve drawdown by at least 20% and 5 percentage points, and stay below 95% exposure; the ranking weights return retention 60% and drawdown improvement 40%.

Strategy · parametersCAGRMDDSharpeCalmarTotalTradesExposure
ADX / DI 방향성
period=34, threshold=15
21.9%-41.8%0.660.523.3x2129%
SMA 크로스오버
fast=39, slow=72
18.1%-58.9%0.580.312.7x2143%
EMA 크로스오버
fast=36, slow=75
15.0%-74.2%0.520.202.3x1542%
Donchian 채널 돌파
entryN=12, exitN=57
11.0%-84.6%0.480.131.9x2572%
ROC 모멘텀
n=73, threshold=-0.01
12.1%-64.9%0.480.192.0x5345%
Supertrend
period=16, mult=4.2
9.3%-85.4%0.440.111.7x1949%
볼린저 밴드 돌파
n=45, k=2.5
9.6%-43.2%0.430.221.7x1721%
Keltner 채널 돌파
emaPeriod=31, atrPeriod=13, mult=2.6
7.3%-41.1%0.370.181.5x1515%
Parabolic SAR
step=0.015, maxStep=0.24
4.2%-72.1%0.350.061.3x11545%
MACD
fast=8, slow=49, signal=10
1.4%-79.0%0.300.021.1x11247%
Buy and hold3.3%-91.5%0.430.041.2x1100%
1x 2021 2022 2023 2024 2025 2026 ADX / DI 방향성Buy and hold
ADX / DI 방향성: Solid strategy line versus dashed buy-and-hold line. Log scale.
0% -23% -46% -69% -92% 2021 2022 2023 2024 2025 2026 Buy and holdADX / DI 방향성
ADX / DI 방향성 maximum drawdown -41.8% (2021-01-19 → 2024-01-24), recovered after 1,142 days.

Rules of the top strategy

Looks at both the direction and the strength of the trend; holds only in a strong uptrend.

Method and caveats

Past performance does not guarantee future returns. Parameters were carried forward from the latest full optimization and replayed on this monthly dataset. 0.5% trading costs are included; taxes, slippage and rejected orders are not.
Re-optimize the same period and setupAll asset reports

Read next